Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Sickle Cell Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global sickle cell disease treatment market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026.

Sickle cell disease (SCD) is a genetic red blood cell (RBC) disorder that affects hemoglobin, a protein that carries oxygen throughout the body. It leads to many complications, such as acute chest syndrome, anemia, and vaso-occlusive crisis (VOC). At present, blood and bone marrow transplant is commonly suggested by doctors for treating SCD. It involves replacing affected bone marrow with a healthy substitute received from a donor. Other effective treatments, such as medications and blood transfusions, are also being utilized as they can reduce specific symptoms and prolong the life of patients.

A considerable increase in the number of individuals suffering from SCD represents one of the significant factors influencing the demand for new medications that can treat the condition effectively. As a result, the health regulatory authorities of numerous countries are focusing on fast-track approval of new treatment methods. For instance, the United States Food and Drug Administration (USFDA) approved a new medicine in 2019 to reduce the pain experienced by adults and children with SCD. Additionally, government authorities are supporting research and development (R&D) activities to encourage researchers and pharmaceutical companies to develop novel treatments. For instance, researchers at the National Heart, Lung, and Blood Institute (NHLBI) in the US are working on genetic therapies that can restore a missing gene or add a new DNA strain to improve the functioning of cells. These innovations, along with the rising disposable incomes and the growing awareness among individuals about the available healthcare services, are anticipated to contribute to market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global sickle cell disease treatment market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, treatment type and end user.

Breakup by Treatment Type:

  • Blood Transfusion
  • Pharmacotherapy
  • Bone Marrow Transplant
     

Breakup by End User:

  • Hospitals
  • Diagnostic centers
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca Plc, Baxter International Inc., bluebird bio Inc., Bristol-Myers Squibb Company, CRISPR Therapeutics, Emmaus Medical Inc., Global Blood Therapeutics Inc., GlycoMimetics Inc., Novartis AG, Pfizer Inc. and Sangamo Therapeutics.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Treatment Type, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AstraZeneca Plc, Baxter International Inc., bluebird bio Inc., Bristol-Myers Squibb Company, CRISPR Therapeutics, Emmaus Medical Inc., Global Blood Therapeutics Inc., GlycoMimetics Inc., Novartis AG, Pfizer Inc. and Sangamo Therapeutics.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global sickle cell disease treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global sickle cell disease treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global sickle cell disease treatment market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Sickle Cell Disease Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Treatment Type
    6.1    Blood Transfusion
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Pharmacotherapy
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Bone Marrow Transplant
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by End User
    7.1    Hospitals
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Diagnostic centers
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    AstraZeneca Plc
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Baxter International Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    bluebird bio Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bristol-Myers Squibb Company
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
           13.3.4.3 Financials
           13.3.4.4 SWOT Analysis
        13.3.5    CRISPR Therapeutics
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
        13.3.6    Emmaus Medical Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
        13.3.7    Global Blood Therapeutics Inc.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
        13.3.8    GlycoMimetics Inc.
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
        13.3.9    Novartis AG
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Pfizer Inc.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis
        13.3.11    Sangamo Therapeutics
           13.3.11.1 Company Overview
           13.3.11.2 Product Portfolio
           13.3.11.3 Financials
           13.3.11.4 SWOT Analysis

List of Figures

Figure 1: Global: Sickle Cell Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Sickle Cell Disease Treatment Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Sickle Cell Disease Treatment Market: Breakup by Treatment Type (in %), 2020
Figure 5: Global: Sickle Cell Disease Treatment Market: Breakup by End User (in %), 2020
Figure 6: Global: Sickle Cell Disease Treatment Market: Breakup by Region (in %), 2020
Figure 7: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Sickle Cell Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Sickle Cell Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Sickle Cell Disease Treatment (Diagnostic centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Sickle Cell Disease Treatment (Diagnostic centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Sickle Cell Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Sickle Cell Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: North America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: North America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: United States: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: United States: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Canada: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Canada: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Asia-Pacific: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Asia-Pacific: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: China: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: China: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Japan: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Japan: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: India: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: India: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: South Korea: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: South Korea: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Australia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Australia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Indonesia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Indonesia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Europe: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Europe: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Germany: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Germany: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: France: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: France: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: United Kingdom: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: United Kingdom: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Italy: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Italy: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Spain: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Spain: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Russia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Russia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Latin America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Latin America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Brazil: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Brazil: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Mexico: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Mexico: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Middle East and Africa: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Middle East and Africa: Sickle Cell Disease Treatment Market: Breakup by Country (in %), 2020
Figure 67: Middle East and Africa: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Global: Sickle Cell Disease Treatment Industry: SWOT Analysis
Figure 69: Global: Sickle Cell Disease Treatment Industry: Value Chain Analysis
Figure 70: Global: Sickle Cell Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Sickle Cell Disease Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 3: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 4: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Sickle Cell Disease Treatment Market: Competitive Structure
Table 6: Global: Sickle Cell Disease Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links